Most Read News

Dr Lal PathLabs declared a fourth interim dividend of ₹6 per share for 2025, reflecting its strong cash generation and shareholder remittance focus.

In Q4FY25, net interest income (NII) came down 2% YoY at ₹1,563 crore, compared to ₹1,600 crore during the same period last year.

Revenue from operations fell 3.6% YoY, at ₹216.4 crore, from ₹224.4 crore in the March 2024 quarter.

An interim dividend of ₹6 per share has been recommended by the Board of Directors for approval by the shareholders at the forthcoming AGM

Net profit rose to ₹228 crore, from ₹208.4 crore in the corresponding quarter last year.

EBITDA (Earnings Before Interest, Tax, Depreciation, and Amortisation) during the quarter rose 32% to ₹4,820 crore.

IIP edged up marginally in March 2025, although the picture of prior period revisions was relatively mixed

UltraTech Cement is the only stock that hits 52-week high in Sensex and Nifty

Here are some of the stocks that may see significant price movement today: Gensol Engineering, Oberoi Realty, TVS Motor Company, etc.

Indian shares ended steady in a volatile week that was marred by rising geopolitical tensions while the tarriff war showed signs of abating.